Arcadia Biosciences, Inc. (RKDA)
USD 3.52
(-1.95%)
USD 3.52
(-1.95%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.95 Million USD | -23.84% |
| 2022 | 2.57 Million USD | -42.0% |
| 2021 | 4.43 Million USD | 16.29% |
| 2020 | 3.81 Million USD | 112.49% |
| 2019 | 1.79 Million USD | 891.16% |
| 2018 | 181 Thousand USD | -20.96% |
| 2017 | 229 Thousand USD | -9.13% |
| 2016 | 252 Thousand USD | -14.29% |
| 2015 | 294 Thousand USD | -30.66% |
| 2014 | 424 Thousand USD | -5.78% |
| 2013 | 450 Thousand USD | -49.89% |
| 2012 | 898 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 978 Thousand USD | -46.59% |
| 2024 Q1 | 1.83 Million USD | -6.49% |
| 2023 Q3 | 2.65 Million USD | -16.02% |
| 2023 Q2 | 3.16 Million USD | 22.12% |
| 2023 FY | 1.95 Million USD | -23.84% |
| 2023 Q4 | 1.95 Million USD | -26.31% |
| 2023 Q1 | 2.59 Million USD | 0.78% |
| 2022 Q3 | 3.34 Million USD | 2.05% |
| 2022 Q4 | 2.57 Million USD | -23.07% |
| 2022 FY | 2.57 Million USD | -42.0% |
| 2022 Q1 | 3.23 Million USD | -27.02% |
| 2022 Q2 | 3.27 Million USD | 1.24% |
| 2021 Q4 | 4.43 Million USD | -18.62% |
| 2021 Q3 | 5.44 Million USD | 39.77% |
| 2021 Q2 | 3.89 Million USD | 46.34% |
| 2021 Q1 | 2.66 Million USD | -30.14% |
| 2021 FY | 4.43 Million USD | 16.29% |
| 2020 Q1 | 5.97 Million USD | 232.83% |
| 2020 FY | 3.81 Million USD | 112.49% |
| 2020 Q4 | 3.81 Million USD | -59.52% |
| 2020 Q2 | 8.77 Million USD | 46.91% |
| 2020 Q3 | 9.41 Million USD | 7.34% |
| 2019 Q4 | 1.79 Million USD | -2.66% |
| 2019 FY | 1.79 Million USD | 891.16% |
| 2019 Q1 | 187 Thousand USD | 3.31% |
| 2019 Q2 | 839 Thousand USD | 348.66% |
| 2019 Q3 | 1.84 Million USD | 119.67% |
| 2018 FY | 181 Thousand USD | -20.96% |
| 2018 Q2 | 282 Thousand USD | -8.74% |
| 2018 Q1 | 309 Thousand USD | 34.93% |
| 2018 Q4 | 181 Thousand USD | -48.87% |
| 2018 Q3 | 354 Thousand USD | 25.53% |
| 2017 Q1 | 242 Thousand USD | -3.97% |
| 2017 Q2 | 286 Thousand USD | 18.18% |
| 2017 FY | 229 Thousand USD | -9.13% |
| 2017 Q3 | 236 Thousand USD | -17.48% |
| 2017 Q4 | 229 Thousand USD | -2.97% |
| 2016 Q1 | 316 Thousand USD | 7.48% |
| 2016 Q4 | 252 Thousand USD | -30.0% |
| 2016 Q3 | 360 Thousand USD | 17.65% |
| 2016 Q2 | 306 Thousand USD | -3.16% |
| 2016 FY | 252 Thousand USD | -14.29% |
| 2015 Q4 | 294 Thousand USD | -50.84% |
| 2015 FY | 294 Thousand USD | -30.66% |
| 2015 Q3 | 598 Thousand USD | 4.55% |
| 2015 Q1 | 521 Thousand USD | 22.88% |
| 2015 Q2 | 572 Thousand USD | 9.79% |
| 2014 Q3 | 443 Thousand USD | -51.27% |
| 2014 Q4 | 424 Thousand USD | -4.29% |
| 2014 Q2 | 909 Thousand USD | 0.0% |
| 2014 FY | 424 Thousand USD | -5.78% |
| 2014 Q1 | - USD | -100.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q4 | 450 Thousand USD | 0.0% |
| 2013 FY | 450 Thousand USD | -49.89% |
| 2012 FY | 898 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Bioceres Crop Solutions Corp. | 126.22 Million USD | 98.449% |
| N2OFF, Inc. | 121.51 Thousand USD | -1511.35% |
| Yield10 Bioscience, Inc. | - USD | -Infinity% |